MYGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $5,474,702.64

Myriad Genetics Insider Trading History Chart

Myriad Genetics Share Price & Price History

^$17.99

▼ -3.97 (-18.08%)

As of 11/1/2024 01:00 AM ET

Days: 30 | 90 | 365

Ex WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction

From Paradigm Press | Ad

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

Myriad Genetics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/11/2024	Paul J Diaz	CEO	Sell	15,000	$22.93	$343,950.00	962,378
9/9/2024	Heinrich Dreismann	Director	Sell	10,000	$27.05	$270,500.00	121,648
9/3/2024	Colleen F Reitan	Director	Sell	46,012	$27.95	$1,286,035.40	42,533
6/3/2024	Daniel K. Spiegelman	Director	Sell	3,788	$22.04	$83,487.52	36,705
5/15/2024	Paul J Diaz	CEO	Sell	75,000	$25.07	$1,880,250.00	1,066,166
5/13/2024	Lee Nisley Newcomer	Director	Sell	6,200	$25.30	$156,860.00	66,650
5/13/2024	Paul J Diaz	CEO	Sell	57,844	$25.13	$1,453,619.72	1,236,166
11/1/2023	Richard Bryan Riggsbee	CFO	Sell	30,000	$15.69	$470,700.00	321,812
6/2/2023	Daniel K. Spiegelman	Director	Sell	8,638	$23.01	$198,760.38	40,493
3/27/2023	Nicole Lambert	COO	Sell	6,433	$23.48	$151,046.84	240,506
1/20/2023	Richard Bryan Riggsbee	CFO	Sell	9,400	$20.04	$188,376.00	364,107
1/18/2023	Richard Bryan Riggsbee	CFO	Sell	600	$20.01	$12,006.00	373,507
12/27/2022	Richard Bryan Riggsbee	CFO	Sell	20,000	$15.15	$303,000.00	374,107
6/6/2022	Daniel K. Spiegelman	Director	Sell	6,424	$19.25	$123,662.00	33,980
2/28/2022	Jayne B. Hart	Insider	Sell	10,500	$25.00	$262,500.00

Banking failure dead ahead

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Myriad Genetics (NASDAQ:MYGN)

99.02% of Myriad Genetics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Myriad Genetics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/1/2024	Atria Investments Inc	11,414	$0.31M	0.0%	+5.4%	0.013%
10/31/2024	Principal Financial Group Inc.	428,023	$11.72M	0.0%	-4.8%	0.471%
10/30/2024	Amalgamated Bank	26,656	$0.73M	0.0%	-2.8%	0.029%
10/25/2024	New York State Teachers Retirement System	73,900	$2.02M	0.0%	+4.4%	0.081%
10/25/2024	China Universal Asset Management Co. Ltd.	17,468	$0.48M	0.1%	+64.3%	0.019%
10/24/2024	Nisa Investment Advisors LLC	11,417	$0.31M	0.0%	+182.9%	0.013%
10/24/2024	State of Alaska Department of Revenue	51,827	$1.42M	0.0%	-2.5%	0.057%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	3,285	$87K	0.0%	+21.6%	0.004%
10/23/2024	Louisiana State Employees Retirement System	43,900	$1.20M	0.0%	-3.5%	0.049%
10/23/2024	Assenagon Asset Management S.A.	167,233	$4.58M	0.0%	-33.2%	0.185%
10/19/2024	Allspring Global Investments Holdings LLC	4,172	$0.11M	0.0%	-37.9%	0.005%
10/18/2024	Blue Trust Inc.	12,663	$0.35M	0.0%	+12.5%	0.014%
10/17/2024	OmniStar Financial Group Inc.	31,506	$0.86M	0.6%	N/A	0.035%
10/17/2024	Inspire Advisors LLC	7,582	$0.21M	0.0%	N/A	0.008%
10/11/2024	Creative Planning	9,949	$0.27M	0.0%	+9.8%	0.011%
10/10/2024	Essex Investment Management Co. LLC	235,841	$6.46M	1.1%	-1.8%	0.261%
10/10/2024	Inspire Investing LLC	16,967	$0.47M	0.0%	+17.6%	0.019%
10/9/2024	Contravisory Investment Management Inc.	8,371	$0.23M	0.0%	N/A	0.009%
10/9/2024	Clarus Wealth Advisors	8,890	$0.23M	0.1%	-9.5%	0.010%
10/7/2024	GAMMA Investing LLC	1,620	$44K	0.0%	+34.1%	0.002%
10/5/2024	Handelsbanken Fonder AB	27,288	$0.75M	0.0%	+12.8%	0.030%
10/3/2024	SG Americas Securities LLC	23,678	$0.65M	0.0%	N/A	0.026%
9/16/2024	Point72 DIFC Ltd	2,459	$60K	0.0%	N/A	0.003%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	3,362	$82K	0.0%	N/A	0.004%
9/5/2024	Sanctuary Advisors LLC	21,968	$0.54M	0.0%	N/A	0.024%
8/29/2024	Maven Securities LTD	50,000	$1.22M	0.0%	N/A	0.055%
8/19/2024	Point72 Asset Management L.P.	839,456	$20.53M	0.1%	+7.9%	0.927%
8/16/2024	Disciplined Growth Investors Inc. MN	2,087,328	$51.06M	1.0%	+0.5%	2.306%
8/16/2024	Algert Global LLC	9,048	$0.22M	0.0%	N/A	0.010%
8/15/2024	Susquehanna Fundamental Investments LLC	94,624	$2.32M	0.1%	N/A	0.105%
8/15/2024	The Manufacturers Life Insurance Company	50,071	$1.23M	0.0%	+9.9%	0.055%
8/15/2024	D. E. Shaw & Co. Inc.	1,126,747	$27.56M	0.0%	-11.0%	1.245%
8/15/2024	Earnest Partners LLC	4,072,018	$99.60M	0.5%	+3.5%	4.499%
8/15/2024	AQR Capital Management LLC	20,910	$0.51M	0.0%	+17.5%	0.023%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	3,362	$82K	0.0%	N/A	0.004%
8/14/2024	Squarepoint Ops LLC	27,286	$0.67M	0.0%	-68.5%	0.030%
8/14/2024	Point72 Asset Management L.P.	839,456	$20.53M	0.1%	+7.9%	0.927%
8/14/2024	Point72 DIFC Ltd	2,459	$60K	0.0%	N/A	0.003%
8/14/2024	Public Sector Pension Investment Board	199,139	$4.87M	0.0%	+9.7%	0.220%
8/14/2024	ProShare Advisors LLC	19,140	$0.47M	0.0%	-20.2%	0.021%
8/14/2024	Profund Advisors LLC	21,140	$0.52M	0.0%	-50.4%	0.023%
8/13/2024	Thrivent Financial for Lutherans	113,031	$2.77M	0.0%	-2.8%	0.125%
8/13/2024	Sei Investments Co.	2,417,192	$59.13M	0.1%	+5.4%	2.671%
8/13/2024	Public Employees Retirement Association of Colorado	10,997	$0.27M	0.0%	-13.0%	0.012%
8/12/2024	Intech Investment Management LLC	22,012	$0.54M	0.0%	N/A	0.024%
8/12/2024	Inspire Investing LLC	14,429	$0.35M	0.0%	-13.4%	0.016%
8/12/2024	XTX Topco Ltd	12,527	$0.31M	0.0%	N/A	0.014%
8/12/2024	Seven Eight Capital LP	9,662	$0.24M	0.0%	N/A	0.011%
8/12/2024	Hsbc Holdings PLC	28,193	$0.68M	0.0%	N/A	0.031%
8/12/2024	Amalgamated Bank	27,421	$0.67M	0.0%	-2.9%	0.030%
8/9/2024	Dimensional Fund Advisors LP	2,776,959	$67.92M	0.0%	+2.8%	3.068%
8/8/2024	Envestnet Asset Management Inc.	77,774	$1.90M	0.0%	+14.5%	0.086%
8/8/2024	Federated Hermes Inc.	56,807	$1.39M	0.0%	+1.5%	0.063%
8/8/2024	Beverly Hills Private Wealth LLC	15,647	$0.38M	0.1%	-6.8%	0.017%
8/8/2024	American Century Companies Inc.	50,805	$1.24M	0.0%	+8.2%	0.056%
8/7/2024	Headlands Technologies LLC	6,624	$0.16M	0.0%	N/A	0.007%
8/7/2024	Texas Permanent School Fund Corp	88,278	$2.16M	0.0%	+13.9%	0.098%
8/6/2024	Quest Partners LLC	5,304	$0.13M	0.0%	+10,724.5%	0.006%
8/5/2024	Arizona State Retirement System	25,160	$0.62M	0.0%	+3.4%	0.028%
8/5/2024	Victory Capital Management Inc.	59,797	$1.46M	0.0%	-5.9%	0.066%
8/1/2024	Rhumbline Advisers	283,435	$6.93M	0.0%	+2.4%	0.313%
8/1/2024	Natixis Advisors LLC	275,367	$6.74M	0.0%	+15.5%	0.304%
7/29/2024	Peregrine Capital Management LLC	305,217	$7.47M	0.2%	+1.3%	0.337%
7/29/2024	Principal Financial Group Inc.	449,606	$11M	0.0%	-4.2%	0.497%
7/29/2024	Innealta Capital LLC	1,466	$36K	0.0%	N/A	0.002%
7/26/2024	Legato Capital Management LLC	45,916	$1.12M	0.2%	N/A	0.051%
7/26/2024	Allspring Global Investments Holdings LLC	6,721	$0.16M	0.0%	-23.7%	0.007%
7/26/2024	Bank of New York Mellon Corp	719,291	$17.59M	0.0%	+4.1%	0.795%
7/24/2024	Louisiana State Employees Retirement System	45,500	$1.11M	0.0%	+3.9%	0.050%
7/22/2024	Fifth Third Bancorp	81,754	$2M	0.0%	+1.4%	0.090%
7/20/2024	Neo Ivy Capital Management	3,488	$85K	0.0%	N/A	0.004%
7/18/2024	Blue Trust Inc.	11,259	$0.28M	0.0%	+26.6%	0.012%
7/18/2024	Assenagon Asset Management S.A.	250,524	$6.13M	0.0%	+26.7%	0.277%
7/12/2024	Hexagon Capital Partners LLC	1,143	$28K	0.0%	+75.3%	0.001%
7/11/2024	Clarus Wealth Advisors	9,822	$0.25M	0.1%	N/A	0.011%
6/4/2024	DekaBank Deutsche Girozentrale	35,272	$0.75M	0.0%	+9.2%	0.039%
5/17/2024	Comerica Bank	79,983	$1.71M	0.0%	-3.4%	0.088%
5/17/2024	Tidal Investments LLC	28,432	$0.61M	0.0%	N/A	0.031%
5/16/2024	California State Teachers Retirement System	88,787	$1.89M	0.0%	+3.0%	0.098%
5/15/2024	Earnest Partners LLC	3,933,058	$83.85M	0.4%	+0.5%	4.345%
5/15/2024	Price T Rowe Associates Inc. MD	53,568	$1.14M	0.0%	+13.4%	0.059%
5/15/2024	Lazard Asset Management LLC	21,143	$0.45M	0.0%	+74.6%	0.023%
5/14/2024	CANADA LIFE ASSURANCE Co	103,498	$2.20M	0.0%	+7.4%	0.114%
5/14/2024	American International Group Inc.	47,331	$1.01M	0.0%	+6.8%	0.052%
5/13/2024	UniSuper Management Pty Ltd	21,917	$0.47M	0.0%	N/A	0.024%
5/13/2024	Ameritas Investment Partners Inc.	8,747	$0.19M	0.0%	+9.0%	0.010%
5/10/2024	Vanguard Group Inc.	10,035,708	$213.96M	0.0%	+0.8%	11.092%
5/9/2024	State Board of Administration of Florida Retirement System	25,107	$0.58M	0.0%	+8.9%	0.028%
5/8/2024	ProShare Advisors LLC	23,993	$0.51M	0.0%	+14.2%	0.027%
5/8/2024	Inspire Investing LLC	16,655	$0.36M	0.0%	-17.6%	0.018%
5/7/2024	Sei Investments Co.	2,293,185	$48.89M	0.1%	+6.1%	2.534%
5/7/2024	Swiss National Bank	174,700	$3.73M	0.0%	+8.2%	0.193%
5/7/2024	AMH Equity Ltd	110,000	$2.35M	2.3%	N/A	0.122%
5/7/2024	SG Americas Securities LLC	21,805	$0.47M	0.0%	-36.7%	0.024%
5/6/2024	Texas Permanent School Fund Corp	77,485	$1.65M	0.0%	+1.2%	0.086%
5/2/2024	Nordea Investment Management AB	128,903	$2.77M	0.0%	+5.6%	0.142%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	334,717	$7.62M	0.0%	+80.5%	0.370%
4/30/2024	Allspring Global Investments Holdings LLC	8,805	$0.19M	0.0%	+90.9%	0.010%
4/29/2024	Principal Financial Group Inc.	469,330	$10.01M	0.0%	-0.5%	0.519%
4/29/2024	China Universal Asset Management Co. Ltd.	17,240	$0.37M	0.0%	+68.1%	0.019%

Data available starting January 2016

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and pharmacogenomics. It also provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing test to help determine the therapy for patients with metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic Test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. The company also offers Prolaris Prostate Cancer Prognostic Test, an RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic Test, an RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor, a solution for precision oncology; and Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus. It provides Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; SneakPeek, a non-invasive blood test that predicts the gender of a fetus; and GeneSight Psychotropic Mental Health Medication Test, a DNA genotyping test to aid psychotropic drug selection for patients suffering from depression, anxiety, attention-deficit, hyperactivity disorder, and other mental health conditions. It has a strategic collaboration with Illumina, Inc., Memorial Sloan Kettering Cancer Center, the University of Texas MD Anderson Cancer Center, SimonMed, and Onsite Women's Health. Myriad Genetics, Inc. was incorporated in 1992 and is headquartered in Salt Lake City, Utah.

Today's Range

Now: $17.99

$16.86

$20.06

50 Day Range

MA: $25.57

$17.99

$28.60

52 Week Range

Now: $17.99

$15.78

$29.30

Volume

3,737,508 shs

Average Volume

718,504 shs

Market Capitalization

$1.63 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.91

Who are the company insiders with the largest holdings of Myriad Genetics?: Myriad Genetics' top insider investors include:
Paul J Diaz (CEO)
Richard Bryan Riggsbee (CFO)
Nicole Lambert (COO)
Heinrich Dreismann (Director)
Lee Nisley Newcomer (Director)
Colleen F Reitan (Director)
Daniel K Spiegelman (Director)
Learn More about top insider investors at Myriad Genetics.
Who are the major institutional investors of Myriad Genetics?: Myriad Genetics' top institutional investors include:
Principal Financial Group Inc. — 0.47%
Essex Investment Management Co. LLC — 0.26%
Assenagon Asset Management S.A. — 0.18%
New York State Teachers Retirement System — 0.08%
State of Alaska Department of Revenue — 0.06%
Louisiana State Employees Retirement System — 0.05%
Learn More about top institutional investors of Myriad Genetics stock.
Which major investors are selling Myriad Genetics stock?: During the previous quarter, MYGN stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Principal Financial Group Inc.
Essex Investment Management Co. LLC
Allspring Global Investments Holdings LLC
Louisiana State Employees Retirement System
State of Alaska Department of Revenue
Clarus Wealth Advisors
Amalgamated Bank
In the last year, company insiders that have sold Myriad Genetics company stock include:
Paul J Diaz (CEO)
Richard Bryan Riggsbee (CFO)
Nicole Lambert (COO)
Heinrich Dreismann (Director)
Lee Nisley Newcomer (Director)
Learn More investors selling Myriad Genetics stock.
Which major investors are buying Myriad Genetics stock?: In the last quarter, MYGN stock was acquired by institutional investors including:
OmniStar Financial Group Inc.
SG Americas Securities LLC
Contravisory Investment Management Inc.
Inspire Advisors LLC
Nisa Investment Advisors LLC
China Universal Asset Management Co. Ltd.
New York State Teachers Retirement System
Handelsbanken Fonder AB